Report Description

Global genetic engineering tool market is expected to show robust growth in the forecast years 2024-2028. This can be ascribed to the increasing advancements in the field of biotechnology and genetics. Growing popularity of genomic medicine and personalized medicine is driving the growth of the global genetic engineering tool market in the coming years. As of 2020, the number of personalized medicine available in the United States were around 286.

The process of using recombinant Deoxyribonucleic Acid (rDNA) technology to create alterations in the genetic map of an organism is categorized as genetic engineering. These altercations are done through various biotechnological processes like insertion, deletion, CRISPR, etc. These techniques are termed as genetic engineering tools. Genetic modifications have various purposes like pharmaceutical production, protein enhancement, genetic studies, etc., and thus genetic engineering tools are rapidly being introduced, and consistent research is being carried out.

Pharmaceutical Industry Growth Drives Market Growth

The Healthcare industry is rapidly expanding globally, and increasing financial aids for the development of healthcare industry are further creating lucrative opportunities for the growth of market growth. One of the sectors, the pharmaceutical sector, is most advancing and registers phenomenal growth in the coming years due to the extended utilization of genetic engineering tools in their production, designing, and manufacturing. The rapid growth of precision medicine, genomic medicine, and other advanced methods of therapeutics is further aiding the growth of the global genetic engineering tools market in the upcoming five years.

The first-ever successful product of genetic engineering in the pharmaceutical industry was protein drugs like insulin. Micro-organisms used as bioreactors were utilized to multiply the quantity of the protein and thus mass-produced the drug. Transgenic animals and transgenic plants are also utilized for the production of various protein drugs that are not possible to be produced in the micro-organisms.

Research & Technology Development Support Market Growth

Genetic engineering is a consistently developing sector of biotechnology. With prolonging and continuous research going on related to gene editing and genome manipulating studies, the global genetic engineering tool market is bound to register robust growth in the coming years. With the prevalence of chronic diseases and the surging demand for therapeutic approaches toward those diseases, the global genetic engineering tool market is supporting growth in the forecast period.

Minichromosomal technology and RNA transcription alterations are some of the major genetic engineering tools expecting more research, thereby supporting the growth of the global genetic engineering tools market in the coming years. CRISPR-Cas9 gene altercations is a gene therapy that is expected to aid market growth. Moreover, genetic engineering has various applications. Further applications of the genetic engineering tools in genome modification are another prospective research segment that would drive the growth of the Global Genetic Engineering Tools market in the forecast years. 

Genetic Engineering in Agriculture

Demands of advancement in the agriculture sector with the help of genetic engineering are further substantiating the growth of the global genetic engineering tool market in the coming years. According to the biotech lobbying group ISAAA, GM crops covered 191.7 million hectares in 2018, an increase of 1% from 2017. With 75 million hectares (39% of the world's area), the United States is the world's largest producer of GM crops. Increased crop yields, reduced costs for food or drug production, reduced need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, greater food security, and medical benefits to the world's growing population are some of the major advantages that involves the use of genetic engineering tools. The involvement of genetic engineering tools in agriculture to produce better crops will also drives the growth of the Global Genetic Engineering Tool market in the coming years.


Download Free Sample Report

Market Segmentation

Global genetic engineering tool market is segmented based on type, therapeutic area, end-user, and region. Based on type, the market is further fragmented into genome-scale editing tools and genome-scale engineering tools. Based on therapeutic area, the market is bifurcated into sickle cell disease, heart disease, diabetes, Alzheimer's disease, obesity, and others. Based on end-user, the market is again sub-segmented into biotechnology & pharmaceutical companies, academic & research institutions, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and the Middle East & African region.

Company Profiles

Thermo Fisher Scientific Inc, CRISPR Therapeutics AG, Editas Medicine, Inc., Intellia Therapeutics, Inc, Merck KGaA, Horizon Discovery Ltd, GeneCopoeia Inc, Takara Bio Inc., Sangamo Therapeutics, Inc., Genscript Biotech Corporation, are among the major market players in the global platform that lead the market growth of the global genetic engineering tool market.

Attribute

Details

Base Year

2022

Historical Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         Therapeutic Area

·         End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Thailand, Singapore, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Israel, Brazil, Argentina, Colombia

Key companies profiled

Thermo Fisher Scientific Inc, CRISPR Therapeutics AG, Editas Medicine, Inc., Intellia Therapeutics, Inc, Merck KGaA, Horizon Discovery Ltd, GeneCopoeia Inc, Takara Bio Inc., Sangamo Therapeutics, Inc., Genscript Biotech Corporation,

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global genetic engineering tool market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genetic Engineering Tool Market, By Type:
    • Genome Scale Editing Tools
      • CRISPR
      • MAGE
      • CRMAGE
      • CREATE
      • Others
    • Genome Scale Engineering Tools
      • Promoter Engineering
      • Ribosomal Binding Site (RBS) Engineering
      • Synthetic Small Regulatory RNA
      • Others
  • Genetic Engineering Tool Market, By Therapeutic Area:
    • Sickle Cell Disease
    • Heart Disease
    • Diabetes
    • Alzheimer’s Disease
    • Obesity
    • Others
  • Genetic Engineering Tool Market, By End User:
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutions
    • Others
  • Genetic Engineering Tool Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Thailand
      • Singapore
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Israel
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genetic engineering tool market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Global Genetic Engineering Tool Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

4.1.  Commonly Used Genetic Engineering Techniques

4.2.  Commonly Used Gene Editing Techniques

4.3.  Benefits of Using Genetic Engineering Tools

4.4.  Preference for Genetic Engineering Tools, By Therapeutic Area

4.5.  Barriers to Adoption of Genetic Engineering Tools

4.6.  Brand Awareness

5.    Global Genetic Engineering Tools Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

5.2.1.1.         Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

5.2.1.2.         Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

5.2.2.     By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

5.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

5.2.4.     By Company (2022)

5.2.5.     By Region

5.3.  Market Map

5.3.1.     By Type

5.3.2.     By Therapeutic Area

5.3.3.     By End User

5.3.4.     By Region

6.    North America Genetic Engineering Tools Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

6.2.1.1.         Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

6.2.1.2.         Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

6.2.2.     By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

6.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Genetic Engineering Tools Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Type

6.3.1.2.2.             By Therapeutic Area

6.3.1.2.3.             By End User

6.3.2.     Mexico Genetic Engineering Tools Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Type

6.3.2.2.2.             By Therapeutic Area

6.3.2.2.3.             By End User

6.3.3.     Canada Genetic Engineering Tools Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Type

6.3.3.2.2.             By Therapeutic Area

6.3.3.2.3.             By End User

7.    Europe Genetic Engineering Tools Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

7.2.1.1.         Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

7.2.1.2.         Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

7.2.2.     By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

7.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Genetic Engineering Tools Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Therapeutic Area

7.3.1.2.3.             By End User

7.3.2.     Germany Genetic Engineering Tools Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Therapeutic Area

7.3.2.2.3.             By End User

7.3.3.     United Kingdom Genetic Engineering Tools Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Therapeutic Area

7.3.3.2.3.             By End User

7.3.4.     Italy Genetic Engineering Tools Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Type

7.3.4.2.2.             By Therapeutic Area

7.3.4.2.3.             By End User

7.3.5.     Spain Genetic Engineering Tools Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Type

7.3.5.2.2.             By Therapeutic Area

7.3.5.2.3.             By End User

8.    Asia-Pacific Genetic Engineering Tools Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

8.2.1.1.         Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

8.2.1.2.         Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

8.2.2.     By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

8.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Genetic Engineering Tools Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Therapeutic Area

8.3.1.2.3.             By End User

8.3.2.     India Genetic Engineering Tools Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Therapeutic Area

8.3.2.2.3.             By End User

8.3.3.     South Korea Genetic Engineering Tools Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Therapeutic Area

8.3.3.2.3.             By End User

8.3.4.     Japan Genetic Engineering Tools Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Therapeutic Area

8.3.4.2.3.             By End User

8.3.5.     Australia Genetic Engineering Tools Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Therapeutic Area

8.3.5.2.3.             By End User

8.3.6.     Thailand Genetic Engineering Tools Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Type

8.3.6.2.2.             By Therapeutic Area

8.3.6.2.3.             By End User

8.3.7.     Singapore Genetic Engineering Tools Market Outlook

8.3.7.1.         Market Size & Forecast

8.3.7.1.1.             By Value

8.3.7.2.         Market Share & Forecast

8.3.7.2.1.             By Type

8.3.7.2.2.             By Therapeutic Area

8.3.7.2.3.             By End User

9.    South America Genetic Engineering Tools Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

9.2.1.1.         Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

9.2.1.2.         Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

9.2.2.     By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

9.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Genetic Engineering Tools Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Therapeutic Area

9.3.1.2.3.             By End User

9.3.2.     Argentina Genetic Engineering Tools Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Therapeutic Area

9.3.2.2.3.             By End User

9.3.3.     Colombia Genetic Engineering Tools Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Therapeutic Area

9.3.3.2.3.             By End User

10.  Middle East and Africa Genetic Engineering Tools Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type (Genome Scale Editing Tools v/s Genome Scale Engineering Tools)

10.2.1.1.      Genome Scale Editing Tools (CRISPR, MAGE, CRMAGE, CREATE, Others)

10.2.1.2.      Genome Scale Engineering Tools (Promoter Engineering, Ribosomal Binding Site (RBS) Engineering, Synthetic Small Regulatory RNA, Others)

10.2.2.  By Therapeutic Area (Sickle Cell Disease, Heart Disease, Diabetes, Alzheimer’s Disease, Obesity, Others)

10.2.3.  By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Genetic Engineering Tools Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Therapeutic Area

10.3.1.2.3.           By End User

10.3.2.  Saudi Arabia Genetic Engineering Tools Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Therapeutic Area

10.3.2.2.3.           By End User

10.3.3.  UAE Genetic Engineering Tools Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Therapeutic Area

10.3.3.2.3.           By End User

10.3.4.  Israel Genetic Engineering Tools Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Type

10.3.4.2.2.           By Therapeutic Area

10.3.4.2.3.           By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Genetic Engineering Tool Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.